Trade Pluri Inc. - PLUR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.6660 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.637 |
| Open | 3.207 |
| 1-Year Change | -41.67% |
| Day's Range | 3.207 - 3.817 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 3.7070 | 0.5000 | 15.59% | 3.2070 | 3.8670 | 3.2070 |
| Apr 16, 2025 | 3.6370 | 0.0900 | 2.54% | 3.5470 | 3.6370 | 3.5470 |
| Apr 15, 2025 | 3.6870 | 0.1400 | 3.95% | 3.5470 | 3.7070 | 3.4070 |
| Apr 14, 2025 | 3.7670 | -0.1000 | -2.59% | 3.8670 | 3.8670 | 3.7170 |
| Apr 11, 2025 | 3.5470 | -0.1400 | -3.80% | 3.6870 | 3.7570 | 3.5470 |
| Apr 10, 2025 | 3.6570 | -0.1500 | -3.94% | 3.8070 | 3.8270 | 3.4370 |
| Apr 9, 2025 | 3.7970 | 0.1200 | 3.26% | 3.6770 | 3.8770 | 3.4270 |
| Apr 8, 2025 | 3.6970 | 0.1900 | 5.42% | 3.5070 | 3.8270 | 3.3770 |
| Apr 7, 2025 | 3.4470 | -0.0300 | -0.86% | 3.4770 | 3.4870 | 3.1470 |
| Apr 4, 2025 | 3.3170 | -0.5700 | -14.66% | 3.8870 | 3.8870 | 3.0670 |
| Apr 3, 2025 | 3.6970 | -0.4400 | -10.64% | 4.1370 | 4.1370 | 3.6970 |
| Apr 2, 2025 | 4.1370 | 0.0400 | 0.98% | 4.0970 | 4.2370 | 4.0870 |
| Apr 1, 2025 | 4.1370 | -0.0200 | -0.48% | 4.1570 | 4.3770 | 4.1370 |
| Mar 31, 2025 | 4.1570 | 0.0100 | 0.24% | 4.1470 | 4.1970 | 4.1470 |
| Mar 28, 2025 | 4.1870 | -0.1500 | -3.46% | 4.3370 | 4.3370 | 4.1870 |
| Mar 27, 2025 | 4.2570 | 0.0700 | 1.67% | 4.1870 | 4.2670 | 4.1870 |
| Mar 26, 2025 | 4.2670 | -0.0200 | -0.47% | 4.2870 | 4.2870 | 4.1470 |
| Mar 25, 2025 | 4.2570 | 0.0400 | 0.95% | 4.2170 | 4.2570 | 4.0470 |
| Mar 24, 2025 | 4.3270 | 0.0300 | 0.70% | 4.2970 | 4.3270 | 4.2970 |
| Mar 21, 2025 | 4.1870 | 0.0400 | 0.96% | 4.1470 | 4.2170 | 3.9770 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Pluri Inc. Company profile
About Pluristem Therapeutics Inc.
Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.
Financial summary
BRIEF: For the six months ended 31 December 2021, Pluristem Therapeutics Inc. revenues was not reported. Net loss increased 6% to $22.4M. Higher net loss reflects General and administrative expenses increase of 30% to $4.8M (expense), Stock-based Compensation in SGA increase of 9% to $4.6M (expense), Research & Development Expense decrease of 75% to $72K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.82 to -$0.70.
Equity composition
Common Stock $0.00001 Par, 01/13, 100M auth., 58,333,206 issd. Insiders control 11.74%. IPO: NA. 11/07,1-for-200 reverse stock split. 11/07, Name changed from Pluristem Life Systems, Inc. 12/07, Exchanged changed from OTC Bulletin Board to NASDAQ.
| Industry: | Biotechnology & Medical Research (NEC) |
Matam Park Building 5
HAIFA
3508409
IL
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com